Kim Sung Eun, Bahta Medhanit, Lountos George T, Ulrich Robert G, Burke Terrence R, Waugh David S
Chemical Biology Laboratory, National Cancer Institute at Frederick, MD 21702-1201, USA.
Acta Crystallogr D Biol Crystallogr. 2011 Jul;67(Pt 7):639-45. doi: 10.1107/S0907444911018610. Epub 2011 Jun 11.
Isothiazolidinone (IZD) heterocycles can act as effective components of protein tyrosine phosphatase (PTP) inhibitors by simultaneously replicating the binding interactions of both a phosphoryl group and a highly conserved water molecule, as exemplified by the structures of several PTP1B-inhibitor complexes. In the first unambiguous demonstration of IZD interactions with a PTP other than PTP1B, it is shown by X-ray crystallography that the IZD motif binds within the catalytic site of the Yersinia pestis PTP YopH by similarly displacing a highly conserved water molecule. It is also shown that IZD-based bidentate ligands can inhibit YopH in a nonpromiscuous fashion at low micromolar concentrations. Hence, the IZD moiety may represent a useful starting point for the development of YopH inhibitors.
异噻唑啉酮(IZD)杂环可通过同时模拟磷酸基团和高度保守水分子的结合相互作用,充当蛋白酪氨酸磷酸酶(PTP)抑制剂的有效成分,几种PTP1B抑制剂复合物的结构即为例证。在首次明确证明IZD与PTP1B以外的其他PTP相互作用时,X射线晶体学表明,IZD基序通过类似地取代一个高度保守的水分子,结合在鼠疫耶尔森菌PTP YopH的催化位点内。还表明基于IZD的双齿配体可以低微摩尔浓度以非混杂方式抑制YopH。因此,IZD部分可能是开发YopH抑制剂的有用起点。